Assembly Biosciences (ASMB) Preferred Shares (2013)
Assembly Biosciences (ASMB) posted quarterly Preferred Shares of $44.0 for Q4 2013, down 80.0% quarter-over-quarter from $220.0 in Q3 2013.
Assembly Biosciences (ASMB) Preferred Shares (2013) Analysis & Trends
Assembly Biosciences' Preferred Shares history runs 1 years deep, the most recent figure standing at $44.0 for Q4 2013.
- In Q4 2013, Preferred Shares changed N/A year-over-year to $44.0; the TTM figure through Dec 2013 stood at $44.0 (changed N/A YoY), while the FY2013 annual figure was $44.0, changed N/A from the prior year.
- Preferred Shares for Q4 2013 stood at $44.0, down from $220.0 in the prior quarter.
- The five-year high for Preferred Shares was $220.0 in Q1 2013, with the low at $44.0 in Q4 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Assembly Biosciences | 670.88 Mn | 350.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 44.00 |
| Sep 30, 2013 | 220.00 |
| Jun 30, 2013 | 220.00 |
| Mar 31, 2013 | 220.00 |